Expression of alternatively spliced forms of the CD44 extracellular‐matrix receptor on human lung carcinomas

International Journal of Cancer

Volumn 57, Issue 8 S, 1994, Pages 110-115

  Jackson, D G ^a   Schenker, T ^b   Waibel, R ^b   Bell, J I ^a   Stahel, R A ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL SURFACE RECEPTOR; HERMES ANTIGEN; HOMING RECEPTOR; MESSENGER RNA; PRIMER DNA;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOSYNTHESIS; CELL CLONE; CELL CULTURE; CELL LINE; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; CONFERENCE PAPER; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; ANTIGENS, CD44; BASE SEQUENCE; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE; CLONE CELLS; CLONING, MOLECULAR; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RECEPTORS, LYMPHOCYTE HOMING; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 33947733673     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910570724     Document Type: Article

References (27)

1. Isolation and characterization of human melanoma‐cell variants expressing high and low levels of CD44
2. Single‐step method of RNA isolation by acid‐guanidinium‐thiocyanate‐phenol‐chloroform extraction
3. The hyaluronate receptor is a member of the CD44 (H‐CAM) family of cell‐surface glycoproteins
4. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte “homing” receptor expressed by hemopoietic cells
5. A cell‐surface chondroitin‐sulfate proteoglycan, immunologically related to CD44, is involved in type‐I‐collagen‐mediated melanoma‐cell motility and invasion
6. CD44 and cancer screening
7. Heterotransplantation of human cancers into nude mice
8. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins
9. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
10. A human homologue of the rat‐metastasis‐associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps
11. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines
12. Identification and characterization of the human Pgp‐1 glycoprotein
13. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain
14. A lymphoid cell‐surface glycoprotein involved in endothelial‐cell recognition and lymphocyte homing in man
15. Lymphocyte CD44 binds the COOH‐terminal heparin‐binding domain of fibronectin
16. Lymphocyte homing and clinical behavior of non‐Hodgkin's lymphoma
17. A family of cell‐surface glycoproteins defined by a putative anti‐endothelial‐cell‐receptor antibody in man
18. The role and regulation of tumour‐associated hyaluronan
19. The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44
20. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types
21. DNA sequencing with chain terminating inhibitors
22. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp‐1 (CD44) homing receptor
23. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
24. A lymphocyte molecule implicated in lymph‐node homing is a member of the cartilage link protein family
25. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells
26. Distinct effects of two CD44 isoforms on tumor growth in vivo
27. Inhibition of tumor growth in vivo with a soluble CD44‐immunoglobulin fusion protein